Co-Founder And Ceo (We Are Hiring!)
CurrentGenetica, with its proprietary gene testing technology, has been at the forefront of serving the Asian population as it moves toward the inevitable precision medicine and personalized preventative care.Genetica offers low-cost gene test solutions to the Southeast Asian market. It decodes hundreds of genes and nearly a million variants to provide its users with detailed personalized reports on optimal fitness and diet plans, child development, and critical illness prevention (cancers, diabetes, strokes, etc.).Genetica, based in San Francisco, has been one of the region's fastest-growing direct-to-consumer gene testing technology companies, offering low-cost services to Southeast Asians.Genetica's proprietary cutting-edge technology is the result of years of R&D collaboration with leading institutes such as UCSF, Harvard Medical School, Stanford University, Cornell University, Illumina, and Thermo Fisher.According to BCC Research (Direct-to-consumer Genetic Testing Global Market and Technology, December 2020), the lack of proprietary technology for Asian genomics decoding has resulted in a conservative projection of only a 14 percent contribution of Asian genomics data in world databases by 2025. The faster and less expensive we can close the gap, the more accessible personalized care and precision medicine will be for the vast majority of Asians.We continue to look forward to partnering with those who truly understand the technology and are committed to long-term positive social impact.